Studies suggest that consistent use can lead to a gradual reduction in melanin production, resulting in a lighter, more even complexion
Back pain is one of the most common health complaints worldwide, affecting an estimated 619 million people globally
Why are GLP-1 medications not one-size-fits-all
Therefore, the positive results observed in the group treated with ALCAR 1.5 g/day may be due to some unmeasured or uncontrolled variable
Sun Protection: Consistently using sunscreen with a high SPF reduces the risk of UV damage, which the skin may be more sensitive to during treatment
We did not examine posttranslational modifications linked to target degradation such as ubiquitination, but note that the GLP-1R is not ubiquitinated by treatment with exendin-4 (Jones et al., 2018a)